GSK gets CDSCO marketing authorization for Rotavirus Vaccine, Live Attenuated, Oral IP Medical Dialogues Team20 Aug 2021 4:07 PM ISTNew Delhi: The pharmaceutical major, GlaxoSmithKline Pharmaceuticals Limited, has recently received a grant of marketing authorization for Rotavirus...
Delhi HC restrains Micro Lab from infringing Bristol Myers anticoagulant drug Apixaban Medical Dialogues Team19 Aug 2021 5:07 PM ISTNew Delhi: The Delhi High Court has passed an ex-parte ad- interim injunction restraining Micro Labs Limited from infringing any generic Apixaban...
Drug manufacturers to get deemed approval for license if authorities fail to reply in 7 working days Farhat Nasim18 Aug 2021 6:51 PM ISTNew Delhi: Through a recent Gazette notification, the Government has notified a draft amendment in the Drugs Rules, 1945, to add a provision for...
Torrent Pharma Tapentadol Nasal Spray gets CDSCO panel go ahead for phase 3 trial Medical Dialogues Team17 Aug 2021 3:40 PM ISTNew Delhi: The Ahmedabad-based pharmaceutical major, Torrent Pharma, has received permission from the Subject Expert Committee (SEC) of the Central...
Drugs ceiling prices to be revised every 5 years: DoP amends DPCO 2013 Act Medical Dialogues Team16 Aug 2021 3:55 PM ISTNew Delhi: Through a recent gazette notification, Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilizers, has decided...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
44 drug samples including Cipla Remdesivir fail to qualify CDSCO test, 1 declared misbranded Medical Dialogues Team14 Aug 2021 3:11 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 44...
Bharat Biotech study on Covaxin, nasal COVID jab cocktail gets DCGI nod: Report Medical Dialogues Team13 Aug 2021 3:49 PM ISTHyderabad: In a significant advancement in Covid 19 vaccine development, Bharat Biotech has got approval from the Drug Controller General of India...
NPPA finds new Chairman in IAS Kamlesh Kumar Pant Ruchika Sharma12 Aug 2021 11:22 AM ISTNew Delhi: Senior bureaucrat Kamlesh Kumar Pant has been appointed as chairperson of the National Pharmaceutical Pricing Authority (NPPA) as part of...
CDSCO asks stakeholders to submit data on rationality, safety, & efficacy of older FDCs Medical Dialogues Team11 Aug 2021 12:55 PM ISTNew Delhi: In order to assess the status of fixed dose combination drugs licensed prior to 1988, the Directorate General of Health Services, Central...
Pfizer Tafamidis to be sold on prescription of cardiologist only: CDSCO panel Medical Dialogues Team10 Aug 2021 5:24 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Setback to Emcure: NPPA refers back price fixation issue of Darunavir, Ritonavir FDC to DoP Medical Dialogues Team9 Aug 2021 2:14 PM ISTNew Delhi: Holding that data is not available, the National Pharmaceuticals Pricing Authority (NPPA) has referred the matter of fixing the retail...
